Skip to main content

ADx NeuroSciences

Always up-to-date of the latest developments

EventsADx NeuroSciences and Alamar Biosciences announce partnership to provide customized blood-based biomarker assay solutions to accelerate biopharma clinical development
29 October 2024

ADx NeuroSciences and Alamar Biosciences announce partnership to provide customized blood-based biomarker assay solutions to accelerate biopharma clinical development

We’re proud to announce our collaboration with Alamar Biosciences, Inc.!…
NewsPublicationsADx and Fujirebio Join Forces with Biogen and Beckman Coulter to Advance Alzheimer’s Diagnostics
13 August 2024

ADx and Fujirebio Join Forces with Biogen and Beckman Coulter to Advance Alzheimer’s Diagnostics

ADx, together with Fujirebio, is excited to announce a new…
EventsADx will join AAIC 2024
24 July 2024

ADx will join AAIC 2024

We will be present at the 2024 edition of AAIC…
EventsADx will attend AD/PD 2024
28 February 2024

ADx will attend AD/PD 2024

ADx is excited to attend AD/PD 2024 this year in…
otherNewsPublicationsScientific articles in 2024
31 January 2024

Scientific articles in 2024

In 2024, ADx remains committed to fostering collaborative efforts with…
NewsWe officially moved into our new offices!
4 December 2023

We officially moved into our new offices!

More than a year ago our company was welcomed into…
EventsADx will attend AAIC2023
10 July 2023

ADx will attend AAIC2023

ADx is excited to attend AAIC2023 this year in Amsterdam,…
EventsADx is attending CSF society 2024
15 March 2023

ADx is attending CSF society 2024

Come and meet us at the CSF Society Conference in…
NewsPublicationsScientific articles in 2023
31 January 2023

Scientific articles in 2023

In 2023 ADx will continue to collaborate with its research…
EventsADx will attend the clinical workshop CURE-ND in Paris
31 January 2023

ADx will attend the clinical workshop CURE-ND in Paris

On friday February 3rd, ADx NeuroSciences will attend a workshop…
NewsPublicationsFujirebio acquires ADx NeuroSciences and confirms its intentions to bring better and earlier neurodegenerative disease diagnostic solutions to the global diagnostics industry
23 June 2022

Fujirebio acquires ADx NeuroSciences and confirms its intentions to bring better and earlier neurodegenerative disease diagnostic solutions to the global diagnostics industry

Gent, Belgium and Tokyo, Japan, June 23, 2022 – H.U.…
NewsPublicationsScientific articles in 2022
28 January 2022

Scientific articles in 2022

In 2022 ADx will continue to collaborate with its research…
NewsADx NeuroSciences’ review of 2021
19 January 2022

ADx NeuroSciences’ review of 2021

2021 was a remarkable year for ADx. Check out our…
NewsPublicationsScientific articles in 2021
18 January 2022

Scientific articles in 2021

In 2021, ADx NeuroSciences' collaborators worked intensively on groundbreaking scientific…
NewsPublicationsScientific articles in 2020
31 December 2020

Scientific articles in 2020

In 2020, ADx NeuroSciences' collaborators have been intensively participating in…
NewsEventsADx will be present at the upcoming virtual AAIC 2020
1 July 2020

ADx will be present at the upcoming virtual AAIC 2020

Discover the new findings in blood and synaptic biomarkers at…
NewsEventsCancellation ADx Neuro Biomarker Conference
9 April 2020

Cancellation ADx Neuro Biomarker Conference

We regret to announce that the ADx Neuro Biomarker Conference…
NewsEventsADx presents at ADPD results on VAMP2, a new synaptic biomarker showing significant changes in very early pre-clinical disease state.
2 April 2020

ADx presents at ADPD results on VAMP2, a new synaptic biomarker showing significant changes in very early pre-clinical disease state.

While the classical fluid markers, tau and amyloid, accord well…
NewsPublicationsScientific articles in 2019
31 December 2019

Scientific articles in 2019

In 2019, ADx NeuroSciences' collaborators were intensively participating in groundbreaking…
NewsEventsPresent at CTAD 2019
11 December 2019

Present at CTAD 2019

ADx NeuroSciences will be present at CTAD. You can reach…
NewsADx receives funding from Bill Gates for developing blood biomarkers
10 December 2019

ADx receives funding from Bill Gates for developing blood biomarkers

Together with Douglas Galasko, M.D. University of California at San…
NewsPublicationsScientific articles in 2018
31 December 2018

Scientific articles in 2018

ADx NeuroSciences is an R&D company and its people are…